These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 23637956)

  • 1. Over-expression of nerve growth factor-β in human cholangiocarcinoma QBC939 cells promote tumor progression.
    Yue XJ; Xu LB; Zhu MS; Zhang R; Liu C
    PLoS One; 2013; 8(4):e62024. PubMed ID: 23637956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nerve growth factor-beta expression is associated with lymph node metastasis and nerve infiltration in human hilar cholangiocarcinoma.
    Xu LB; Liu C; Gao GQ; Yu XH; Zhang R; Wang J
    World J Surg; 2010 May; 34(5):1039-45. PubMed ID: 20119692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of silencing annexin A5 on proliferation and invasion of human cholangiocarcinoma cell line.
    Ding XM; Li JX; Wang K; Wu ZS; Yao AH; Jiao CY; Qian JJ; Bai DS; Li XC
    Eur Rev Med Pharmacol Sci; 2017 Apr; 21(7):1477-1488. PubMed ID: 28429360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of Wnt/β-catenin signaling in the mesenchymal stem cells promote metastatic growth and chemoresistance of cholangiocarcinoma.
    Wang W; Zhong W; Yuan J; Yan C; Hu S; Tong Y; Mao Y; Hu T; Zhang B; Song G
    Oncotarget; 2015 Dec; 6(39):42276-89. PubMed ID: 26474277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. α7-Nicotinic Acetylcholine Receptor Promotes Cholangiocarcinoma Progression and Epithelial-Mesenchymal Transition Process.
    Chen S; Kang X; Liu G; Zhang B; Hu X; Feng Y
    Dig Dis Sci; 2019 Oct; 64(10):2843-2853. PubMed ID: 30949902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CXCL7 promotes proliferation and invasion of cholangiocarcinoma cells.
    Guo Q; Jian Z; Jia B; Chang L
    Oncol Rep; 2017 Feb; 37(2):1114-1122. PubMed ID: 27959418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Molecular mechanism of γ-aminobutyric acid inhibitory on the growth of cholangiocarcinoma QBC939 cell line].
    Zhu CL; Huang Q; Liu CH; Xie F; Zhu K
    Zhonghua Wai Ke Za Zhi; 2013 Mar; 51(3):261-5. PubMed ID: 23859331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The growth-inhibition effect of tamoxifen in the combination chemotherapeutics on the human cholangiocarcinoma cell line QBC939.
    Liu ZH; He YP; Qin H
    Mol Biol Rep; 2010 Jul; 37(6):2693-701. PubMed ID: 19757172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of Photodynamic Therapy on Apoptosis and Invasion of Human Cholangiocarcinoma QBC939 Cell Line.
    Chen YJ; Jiang HT; Cao JY
    Chin Med Sci J; 2015 Dec; 30(4):252-9. PubMed ID: 26960307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of small interfering RNA targeting p63 on the proliferation and invasiveness of human cholangiocarcinoma cells in vitro].
    Liu Z; Zhang M; Li Y; Zhang Y; She Z
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Feb; 32(2):207-10. PubMed ID: 22381759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelin inhibits cholangiocarcinoma growth by a decrease in the vascular endothelial growth factor expression.
    Fava G; Demorrow S; Gaudio E; Franchitto A; Onori P; Carpino G; Glaser S; Francis H; Coufal M; Marucci L; Alvaro D; Marzioni M; Horst T; Mancinelli R; Benedetti A; Alpini G
    Liver Int; 2009 Aug; 29(7):1031-42. PubMed ID: 19291182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. mir-637 inhibits the proliferation of cholangiocarcinoma cell QBC939 through interfering CTSB expression.
    Li JX; Ding XM; Han S; Wang K; Jiao CY; Li XC
    Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1265-1276. PubMed ID: 29565483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted drug regulation on methylation of p53-BAX mitochondrial apoptosis pathway affects the growth of cholangiocarcinoma cells.
    Liu XF; Jiang H; Zhang CS; Yu SP; Wang ZQ; Su HL
    J Int Med Res; 2012; 40(1):67-75. PubMed ID: 22429346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of ligand pioglitazone activating PPAR-gamma on the invasiveness of cholangiocarcinoma cell in vitro and the expression regulation of related genes].
    Li M; Cheng NS; Xiong XZ; Wu LH; Chen QY; Zhang FQ; Cao GQ
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jun; 38(3):424-7, 487. PubMed ID: 17593822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNA ANRIL promotes the malignant progression of cholangiocarcinoma by epigenetically repressing ERRFI1 expression.
    Yu Y; Chen Q; Zhang X; Yang J; Lin K; Ji C; Xu A; Yang L; Miao L
    Cancer Sci; 2020 Jul; 111(7):2297-2309. PubMed ID: 32378752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PIMREG, a Marker of Proliferation, Facilitates Aggressive Development of Cholangiocarcinoma Cells Partly Through Regulating Cell Cycle-Related Markers.
    Jiang ZM; Li HB; Chen SG
    Technol Cancer Res Treat; 2020; 19():1533033820979681. PubMed ID: 33356974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gamma-aminobutyric acid binds to GABAb receptor to inhibit cholangiocarcinoma cells growth via the JAK/STAT3 pathway.
    Huang Q; Zhu CL; Liu CH; Xie F; Zhu K; Hu SY
    Dig Dis Sci; 2013 Mar; 58(3):734-43. PubMed ID: 23007731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Celecoxib inhibits proliferation and induces apoptosis via prostaglandin E2 pathway in human cholangiocarcinoma cell lines.
    Wu GS; Zou SQ; Liu ZR; Tang ZH; Wang JH
    World J Gastroenterol; 2003 Jun; 9(6):1302-6. PubMed ID: 12800245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antisense RhoC gene suppresses proliferation and invasion capacity of human QBC939 cholangiocarcinoma cells.
    Shi Z; Chen ML; He QL; Zeng JH
    Hepatobiliary Pancreat Dis Int; 2007 Oct; 6(5):516-20. PubMed ID: 17897917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of ZNF703 facilitates tumorigenesis and predicts unfavorable prognosis in patients with cholangiocarcinoma.
    Li K; Wang J; Han J; Lan Y; Xie C; Pan S; Liu L
    Oncotarget; 2016 Nov; 7(46):76108-76117. PubMed ID: 27764785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.